top of page

HELP 4 HD INTERNATIONAL

Stand Up Speak Up 4 HD 🎉 Click Here

Search

uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease

katrina4384
7 hours ago
1 min read

https://uniqure.gcs-web.com/news-releases/news-release-details/uniqure-announces-submission-biologics-license-application

Recent Posts

What is the Difference Between CBER and CDER at the FDA?

What is the Difference Between CBER and CDER at the FDA?

Guilt...for EVERYTHING

Guilt...for EVERYTHING

The first participant has been randomized in the PRECISE-HD Confirmatory study of Pridopidine.

The first participant has been randomized in the PRECISE-HD Confirmatory study of Pridopidine.

Comments

bottom of page